Specialisation
Retina and Vitreous
Full title
A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane versus Lucentis in Patients with Neovascular Age-Related Macular Degeneration
Promoter
Xbrane Biopharma
Start date
June 2019
Researchers
Main: Dr Anniken Burés
Co-Researchers: Dr Rafael Navarro, Dr Borja Corcóstegui, Dr Carlos Mateo, Dr Cecilia Salinas
